137 related articles for article (PubMed ID: 26838194)
1. Are p53 Antibodies a Diagnostic Indicator for Patients with Oral Squamous Cell Carcinoma? Systematic Review and Meta-Analysis.
Yang ZC; Ling L; Xu ZW; Sui XD; Feng S; Zhang J
Asian Pac J Cancer Prev; 2016; 17(1):109-15. PubMed ID: 26838194
[TBL] [Abstract][Full Text] [Related]
2. Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis.
Zhang J; Xv Z; Wu X; Li K
PLoS One; 2012; 7(12):e52896. PubMed ID: 23285221
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the potential diagnostic value of serum p53 antibody for cancer: a meta-analysis.
Zhang J; Xu Z; Yu L; Chen M; Li K
PLoS One; 2014; 9(6):e99255. PubMed ID: 24911057
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of multiple tumor markers for patients with esophageal carcinoma.
Zhang J; Zhu Z; Liu Y; Jin X; Xu Z; Yu Q; Li K
PLoS One; 2015; 10(2):e0116951. PubMed ID: 25693076
[TBL] [Abstract][Full Text] [Related]
5. Potential diagnostic value of serum p53 antibody for detecting colorectal cancer: A meta-analysis.
Meng R; Wang Y; He L; He Y; Du Z
Oncol Lett; 2018 Apr; 15(4):5489-5496. PubMed ID: 29556296
[TBL] [Abstract][Full Text] [Related]
6. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
7. Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.
Grimm M; Rieth J; Hoefert S; Krimmel M; Rieth S; Teriete P; Kluba S; Biegner T; Munz A; Reinert S
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3371-84. PubMed ID: 26926692
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Efficacy of Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Meta-Analysis of 66 Studies.
Liu M; Wang SJ; Yang X; Peng H
PLoS One; 2017; 12(1):e0170322. PubMed ID: 28107500
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
10. Potential role of anti-p53 antibody in diagnosis of lung cancer: evidence from a bivariate meta-analysis.
Lei QQ; Liu JW; Zheng H
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):3012-8. PubMed ID: 24302180
[TBL] [Abstract][Full Text] [Related]
11. P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma.
Friedrich RE; Bartel-Friedrich S; Plambeck K; Bahlo M; Klapdor R
Anticancer Res; 1997; 17(4B):3183-4. PubMed ID: 9329632
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis.
Wang M; Zhang L; Ren W; Li S; Zhi K; Zheng J; Gao L
Front Oncol; 2021; 11():693284. PubMed ID: 34307158
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
Cheng D; Sun Y; He H
Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
[TBL] [Abstract][Full Text] [Related]
15. Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.
Ren W; Gao L; Li F; Qiang C; Li S; Zheng J; Kong X; Deng J; Cai G; Zhang H; Zhou M; Zhi K
J Oral Pathol Med; 2017 Nov; 46(10):998-1003. PubMed ID: 28650082
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as a Novel Class of Diagnostic Biomarkers in Detection of Oral Carcinoma: a Meta-Analysis Study.
Lin N; Lin Y; Fu X; Wu C; Xu J; Cui Z; Lin D
Clin Lab; 2016; 62(3):451-61. PubMed ID: 27156336
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis.
Rapado-González O; Martínez-Reglero C; Salgado-Barreira A; López-López R; Suárez-Cunqueiro MM; Muinelo-Romay L
Oral Oncol; 2019 Dec; 99():104465. PubMed ID: 31756680
[TBL] [Abstract][Full Text] [Related]
18. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
Huang J; Chen J; Huang Q
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
[TBL] [Abstract][Full Text] [Related]
20. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis.
Chang Y; Liu B; Niu H; Wang Z; Xia S; Li H
Medicine (Baltimore); 2020 Aug; 99(34):e21887. PubMed ID: 32846849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
